Press release
Market Driver Insights: The Impact of Recent Advances on the Specific Antiviral Drugs for COVID-19 Market
Specific Antiviral Drugs For COVID 19 Market
Projected Market Value and Growth of Specific Antiviral Drugs for COVID-19
The market for specific antiviral drugs targeting COVID-19 is projected to expand rapidly in the coming years. By 2030, its value is expected to reach $33.17 billion, growing at a compound annual growth rate (CAGR) of 16.8%. This surge is driven by advancements in next-generation antiviral medications, stronger collaborations between public and private sectors, increased use of preventive treatments, broader adoption of combination therapies, and the integration of personalized medicine strategies. Key trends shaping this growth include growing investments in COVID-19 antiviral drug research, a rising preference for oral antiviral tablets, expansion of monoclonal antibody therapies, wider distribution through hospital and retail channels, and a focus on targeted treatments for hospitalized and high-risk patients.
Download a free sample of the specific antiviral drugs for covid 19 market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24713&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Prominent Companies Leading the Specific Antiviral Drugs for COVID-19 Market
Several well-established pharmaceutical companies dominate the specific antiviral drugs market for COVID-19. Among them are Pfizer Inc., Merck & Co. Inc., Gilead Sciences Inc., Shionogi & Co. Ltd., Cipla Limited, Hetero Drugs Limited, Roche Holding AG, Johnson & Johnson, Novartis AG, GSK plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Limited, Atea Pharmaceuticals Inc., Enanta Pharmaceuticals Inc., RedHill Biopharma Ltd., Synairgen plc, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Lupin Limited, Natco Pharma Ltd., Zydus Lifesciences Ltd., Viatris Inc., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Apotex Inc., and Mylan N.V.
Significant Collaborations Advancing COVID-19 Vaccine Development
In July 2024, UK-based GSK plc partnered with CureVac, a Germany-based biotech firm, to jointly develop and commercialize next-generation mRNA vaccines targeting COVID-19 and influenza. This collaboration is aimed at creating innovative mRNA-based vaccines to enhance global public health outcomes by improving the prevention of these infectious diseases.
View the full specific antiviral drugs for covid 19 market report:
https://www.thebusinessresearchcompany.com/report/specific-antiviral-drugs-for-covid-19-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Current Trends in the Specific Antiviral Drugs for COVID-19 Market
Leading pharmaceutical companies are concentrating on developing novel therapies, particularly oral antiviral treatments, to improve accessibility and treatment effectiveness. Oral antivirals offer the convenience of at-home medication that inhibits viral replication, providing a promising option for patients. For example, in March 2024, Japan's Shionogi & Co. launched Xocova and received full approval from the Ministry of Health, Labour and Welfare for the antiviral drug ensitrelvir. This medication not only effectively treats COVID-19 but also serves as post-exposure prophylaxis by lowering the risk of symptomatic infection in exposed individuals and shortening the duration of symptoms, all while maintaining a strong safety profile.
Breakdown of Key Segments Driving Market Expansion for Specific Antiviral Drugs for COVID-19
This market is categorized based on several important segments:
1) Type: Tablet and Injection
2) Indication: Hospitalized Patients, Non-Hospitalized Patients, and Preventive Treatments
3) Drug Class: Nucleoside Analogues, Protease Inhibitors, Ribonucleic Acid Polymerase Inhibitors, Entry Inhibitors, and Monoclonal Antibodies
4) Route of Administration: Oral, Intravenous, Subcutaneous, and Inhalation
5) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Other Channels
Further subcategories include:
- Tablet forms such as Oral Antiviral Tablets, Combination Tablets, and Extended-Release Tablets
- Injection types including Intravenous (IV), Intramuscular (IM), and Subcutaneous injections
This detailed segmentation highlights the diverse range of products and delivery methods contributing to the growth and accessibility of specific antiviral drugs for COVID-19.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Market Driver Insights: The Impact of Recent Advances on the Specific Antiviral Drugs for COVID-19 Market here
News-ID: 4501610 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for COVID
COVID-19 Diagnostics Market Analysis and Forecast to 2033: COVID-19 and Post-COV …
The COVID-19 diagnostics market is projected to reach a size of US$ 79.41 billion in 2023, with a robust compound annual growth rate (CAGR) of 7.87% from 2023 to 2033. This growth is primarily driven by technological advancements in diagnostic tools and methodologies, enabling faster and more accurate detection of the virus. However, the market faces several challenges, including the perception of high costs, along with concerns regarding test accuracy…
COVID-19 Molecular Diagnostics Market Insights by 2027 & Covid-19 Analysis | BD, …
This detailed assessment COVID-19 Molecular Diagnostics market report highlights data about various aspects, which includes growth factors and restraints. Crucial information about market scenario provided in this market report greatly helps key stakeholder in making right decision before making an investment in the market. This report further provides an overview on well-known industries, their market contribution, successful market strategies and latest advancements in present contexts. It also covers market analysis…
Europe COVID-19 Diagnostic Market Size | COVID-19 Impact Analysis | Forecast to …
Europe COVID-19 Diagnostic market is estimated to reach $2.6 billion in 2027, by growing at a CAGR of -22.9 % during the forecast period (2021-2027). Several projects for the development of COVID-19, diagnosis, and treatment were reported over the last few months. Additionally, on 22 July 2020, the European Commission declared nearly $117.8 million to co-fund a call for supporting R&D of coronavirus vaccines, and to develop diagnostic tests, treatments,…
Anti-Covid nasal spray Market (Covid-19 Impact)| Game Changer For Globe | SaNOti …
Global Anti-Covid nasal spray Market Size, Status and Forecast 2026
Israel and New Zealand have given interim approval for the sale of biotech firm SaNOtize Research and Development’s Nitric Oxide Nasal Spray (NONS) which could help prevent transmission of the COVID-19 virus, the company said on Monday. (Reuters)
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19 viral load in infected…
Global COVID-19 Pipeline Assessment 2020 Growth, COVID Impact, Trends Analysis R …
The recent novel coronavirus (COVID-19) outbreak, originating from China, is rampaging across the globe. According to the Worldometers, global coronavirus cases reached over 1.4 million with death toll around 83,000 as of 8th April 2020. With nearly 400,500 infected persons, the US is majorly affected due to the virus spread. The US followed by Spain and Italy with cases around 146,690 and 135,586 respectively as of 8th April 2020. With…
Automation Solutions Market 2020 - Pre-COVID-19 and Post-COVID-19 Comparison
Automation Solutions Industry 2020 Market Research Report" A new report added by DeepResearchReports.com to its research database. Automation Solutions Market is segmented by Regions/Countries. All the key market aspects that influence the Automation Solutions market currently and will have an impact on it have been assessed and propounded in the Automation Solutions market research status and development trends reviewed in the new report.
Download Free PDF Sample @ https://www.deepresearchreports.com/contacts/request-sample.php?name=1302419
Next, learn how…
